Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 11/20 | 0.45 |
| ▸ | CCR3 | P51677 | 6/20 | 0.41 |
| ▸ | TACR2 | P21452 | 3/20 | 0.39 |
| ▸ | RHOC | P08134 | 2/20 | 0.38 |
| ▸ | RHOA | P61586 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3222410 | 1.00 | TACR1 (0.45) | TACR1CCR3TACR2RHOCRHOA | |
| SCHEMBL12809138 | 0.87 | TACR1 (0.46) | TACR1CCR3TACR2RHOCRHOA | |
| SCHEMBL3080781 | 0.87 | TACR1 (0.46) | TACR1CCR3TACR2RHOCRHOA | |
| SCHEMBL3086889 | 0.86 | TACR1 (0.50) | TACR1CCR3TACR2 | |
| SCHEMBL3086886 | 0.86 | TACR1 (0.50) | TACR1CCR3TACR2 | |
| SCHEMBL12809224 | 0.86 | TACR1 (0.49) | TACR1CCR3TACR2RHOCRHOA | |
| SCHEMBL3088212 | 0.86 | TACR1 (0.49) | TACR1CCR3TACR2RHOCRHOA | |
| SCHEMBL4819093 | 0.85 | TACR1 (0.59) | TACR1RHOA | |
| SCHEMBL4819104 | 0.85 | TACR1 (0.59) | TACR1RHOA | |
| SCHEMBL5211430 | 0.85 | TACR1 (0.59) | TACR1RHOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7795261-B2 | Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists | JANSSEN PHARMACEUTICA NV (BE) | 2010-09-14 | — | — | US | claimed |
| EP-1581518-B1 | SUBSTITUTED 1-PIPERIDIN-4-YL-4-PYRROLIDIN-3-YL-PIPERAZINE DERIVATIVES AND THEIR USE AS NEUROKININ ANTAGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2011-03-02 | — | — | EP | disclosed |